| Investopedia … or $0.02 per share, to $10.5 million, or $0.08 per share. What was to blame for the sizable increase in its net loss? Primarily it was a huge gain experienced in 2014 from the revaluation of warrants. … Additionally, Galena shored up its balance … Stock Update (NASDAQ:GALE): Galena Biopharma Inc Reports First Quarter …Smarter Analyst |
